Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

REGISTER for free or LOG IN to view this content

Two-Year Outcomes of the Randomized  Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

We Recommend